Cell Source Inc Annual Return on Equity ROE, Trends, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Cell Source Inc   (CLCS)

CLCS's ROE over the last five Years

Return on Equity, Annual Results, Trends, Rankings, Statistics


Return On Equity (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020
Y / Y Equity Change - - - - -
Y / Y Net Income Change - - - - -
Return On Equity - - - - -

CLCS all Ratios >> Back to CLCS Management Effectiveness >> See Quarterly CLCS Return On Equity

You need to upgrade your Flash Player


Roe Comment
In (Dec 31 2024) ROE detoriated to 24.34 %, despite net income growth.


Financial Statements
Cell Source Inc 's Equity $ -19 Millions Annual CLCS's Balance sheet
Cell Source Inc 's Annual Income $ -5 Millions Annual CLCS's Income Statement
Where are CLCS's Income coming from? Visit CLCS's Income by Segment





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.